Jan 27, 2020
Vancouver, Canada (January 27, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the Company has signed a...
Dec 6, 2019
Vancouver, Canada (December 6, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the development of Epilepsy treatment...
Nov 26, 2019
Vancouver, Canada (November 25, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the Company’s pharmaceutical grade extraction...
Nov 11, 2019
Vancouver, Canada (November 11, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide an update on the Company’s thin...
Nov 4, 2019
Vancouver, Canada (November 04, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that it has signed a term...
Sep 19, 2019
Vancouver, Canada (September 19, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that it has entered into an...
Sep 19, 2019
Vancouver, Canada (September 9, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...
Sep 17, 2019
Vancouver, Canada (September 17, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that it has closed both the...
Aug 26, 2019
Vancouver, Canada (August 26, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that it has entered into a...
Aug 14, 2019
Vancouver, Canada (August 14, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...
Aug 13, 2019
Vancouver, Canada (August 13, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY) (“XPhyto” or the “Company”) is pleased to announce that its common shares have commenced trading...
Aug 6, 2019
Vancouver, Canada (August 6, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY) (“XPhyto” or the “Company”) is pleased to announce that its common shares will commence trading...
Hear about our latest research, products, exclusive partnerships & more.